News
Additionally, Tandem intends to release a software update aimed at enhancing the early detection of speaker failure. The ...
Trinity Biotech (Nasdaq:TRIB) announced today that it unveiled its new flagship continuous glucose monitor (CGM) biosensor ...
This notice comes just weeks after an initial warning about potential underinfusion with all Novum IQ large-volume pumps.
Stevanato Group today announced that it secured $235.5 million (€200 million) in financing to support ongoing capital ...
Medtronic (NYSE:MDT) announced today that it received CE mark to expand its MiniMed 780G's indications, including for type 2 ...
Johnson & Johnson MedTech (NYSE:JNJ) today announced a strategic co-promotion agreement with Pacira BioSciences.
Abbott (NYSE:ABT) today reported Street-beating second-quarter results that included significant growth in its Diabetes ...
Dexcom (Nasdaq:DXCM) has issued an update related to a recall for its continuous glucose monitor (CGM) components.
BD (NYSE:BDX) today announced the first pharma-sponsored combination product clinical trial using its wearable injector technology.
(NYSE:JNJ) announced today that the FDA granted priority review to a new drug application (NDA) for its TAR-200.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results